Breaking News Instant updates and real-time market news.

GKOS

Glaukos

$31.26

-0.93 (-2.89%)

17:30
09/25/17
09/25
17:30
09/25/17
17:30

James E. Flynn reports 7.34% passive stake in Glaukos

GKOS Glaukos
$31.26

-0.93 (-2.89%)

09/14/17
CANT
09/14/17
NO CHANGE
Target $60
CANT
Overweight
Market 'ignoring' that Glaukos 'could own' glaucoma market, says Cantor
Cantor Fitzgerald analyst Elemer Piros said the market "appears to completely ignore" the positive 9-month data on iDose, which could double the number of eligible patients treated with Glaukos' medical devices, while the stock is being punished because the company lowered revenue guidance by about 4% for the rest of this year. The analyst, whose note is partially titled "Glaukos Could Own the Entire Glaucoma Market," keeps an Overweight rating on the stock and raised his price target to $60 from $54.
09/15/17
PIPR
09/15/17
NO CHANGE
Target $38
PIPR
Overweight
Glaukos price target lowered to $38 from $56 at Piper Jaffray
Piper Jaffray analyst Matt O'Brien lowered his price target for Glaukos to $38 saying positive iDose data at yesterday's analyst day was overshadowed by a reduction in guidance that implies a mid-to-high single digit volume in the back half of 2017. More share downside lies ahead in the near term but investors with a 12 months or more timeframe should start buying the name, O'Brien tells investors in a research note. He keeps an Overweight rating on Glaukos.
09/15/17
SPHN
09/15/17
NO CHANGE
Target $47
SPHN
Overweight
Glaukos near-term concerns overshadow pipeline potential, says Stephens
Stephens analyst Chris Cooley said he expects Glaukos' revenue guidance reduction, combined with the expected presentation of clinical data from a competitor at the upcoming American Academy of Ophthalmology meeting to continue to weigh on the stock in the near-term. He lowered his estimates for Glaukos following its analyst day meeting and trimmed his price target to $47 from $49, but maintains an Overweight rating, as none of its near-term headwinds fundamentally alter his view of either its industry leading position or its longer-term opportunity.
09/15/17
WELS
09/15/17
NO CHANGE
Target $42
WELS
Outperform
Wells Fargo cuts Glaukos target, remains bullish on prospects
Wells Fargo analyst Larry Biegelsen lowered his price target for Glaukos to $42 from $53 following the company's first annual investor day. The pipeline updates were "very encouraging," but the near-term outlook appears more challenging as the company lowered its 2017 guidance, Biegelsen tells investors in a research note. He expects the stock to trade sideways until iStent Inject approval in the second half of 2018. The analyst keeps an Outperform rating on Glaukos, saying he remains bullish on its long term prospects and "robust" pipeline.

TODAY'S FREE FLY STORIES

CAR

Avis Budget

$39.94

-0.08 (-0.20%)

15:34
02/21/18
02/21
15:34
02/21/18
15:34
Options
Avis Budget options imply 12.5% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VBTX

Veritex

$27.59

-0.48 (-1.71%)

15:33
02/21/18
02/21
15:33
02/21/18
15:33
Conference/Events
Veritex management to meet with Stephens »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 26

    Feb

  • 27

    Feb

  • 24

    Sep

VBTX

Veritex

$27.59

-0.48 (-1.71%)

15:29
02/21/18
02/21
15:29
02/21/18
15:29
Conference/Events
Veritex management to meet with Stephens »

Meeting to be held in St.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 27

    Feb

  • 24

    Sep

OMER

Omeros

$11.37

0.36 (3.27%)

15:29
02/21/18
02/21
15:29
02/21/18
15:29
Periodicals
Omeros has 'plunging' Omidria sales, 'shaky' balance sheet, Feuerstein says »

Adam Feuerstein of STAT…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TI

Telecom Italia

$8.84

-0.11 (-1.23%)

15:27
02/21/18
02/21
15:27
02/21/18
15:27
Hot Stocks
Telecom Italia says not involved in any anticompetitive behavior »

Regarding today's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KS

KapStone

$34.69

0.14 (0.41%)

15:24
02/21/18
02/21
15:24
02/21/18
15:24
Conference/Events
KapStone management to meet with Stephens »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCBK

TriCo Bancshares

$37.24

-0.76 (-2.00%)

15:19
02/21/18
02/21
15:19
02/21/18
15:19
Conference/Events
TriCo Bancshares management to meet with Stephens »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

AAOI

Applied Optoelectronics

$33.33

1.34 (4.19%)

15:19
02/21/18
02/21
15:19
02/21/18
15:19
Options
Applied Optoelectronics options imply 22.1% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 13

    Mar

  • 29

    Mar

$NSD

NASDAQ Market Internals

15:17
02/21/18
02/21
15:17
02/21/18
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$272.87

1.47 (0.54%)

, SPX

S&P 500

15:16
02/21/18
02/21
15:16
02/21/18
15:16
Technical Analysis
Technical Take: S&P 500 retests lows of the day »

At time of writing the…

SPY

SPDR S&P 500 ETF Trust

$272.87

1.47 (0.54%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$272.87

1.47 (0.54%)

, SPX

S&P 500

15:16
02/21/18
02/21
15:16
02/21/18
15:16
Technical Analysis
Technical Take: S&P 500 retests lows of the day »

At time of writing the…

SPY

SPDR S&P 500 ETF Trust

$272.87

1.47 (0.54%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

15:16
02/21/18
02/21
15:16
02/21/18
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABG

Asbury Automotive

$68.25

0.3 (0.44%)

15:15
02/21/18
02/21
15:15
02/21/18
15:15
Conference/Events
Asbury Automotive management to meet with Stephens »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:15
02/21/18
02/21
15:15
02/21/18
15:15
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

WFC

Wells Fargo

$60.35

0.4 (0.67%)

15:10
02/21/18
02/21
15:10
02/21/18
15:10
Options
Notable call write in Wells Fargo »

Notable call write in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 06

    Mar

  • 07

    Mar

  • 15

    Mar

  • 30

    May

AZN

AstraZeneca

$34.09

0.45 (1.34%)

15:08
02/21/18
02/21
15:08
02/21/18
15:08
Hot Stocks
AstraZeneca announces renewed recommendation, availability of FLUMIST vaccine »

AstraZeneca announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Mar

  • 23

    Apr

P

Pandora

$4.96

-0.375 (-7.04%)

15:04
02/21/18
02/21
15:04
02/21/18
15:04
Options
Pandora options imply 26.6% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 23

    Feb

  • 26

    Feb

  • 05

    Mar

BA

Boeing

$358.70

5.35 (1.51%)

, EADSY

Airbus

$29.67

0.08 (0.27%)

15:03
02/21/18
02/21
15:03
02/21/18
15:03
Periodicals
Boeing displaces Airbus at Hawaiian, Leeham News and Comment says »

Boeing (BA) has displaced…

BA

Boeing

$358.70

5.35 (1.51%)

EADSY

Airbus

$29.67

0.08 (0.27%)

HA

Hawaiian Holdings

$37.35

-1.3 (-3.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 30

    May

NFLX

Netflix

$278.55

0.03 (0.01%)

15:03
02/21/18
02/21
15:03
02/21/18
15:03
Periodicals
Netflix and indie film makers Duplass Brothers in deal, Variety reports »

Variety reported earlier…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 26

    Feb

  • 20

    Mar

MBT

Mobile TeleSystems

$12.66

0.49 (4.03%)

15:00
02/21/18
02/21
15:00
02/21/18
15:00
Options
Call buyers in Mobile TeleSystems as shares reach 52-week highs »

Call buyers in Mobile…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DPZ

Domino's Pizza

$223.26

1.77 (0.80%)

, QSR

Restaurant Brands

$59.54

0.31 (0.52%)

14:50
02/21/18
02/21
14:50
02/21/18
14:50
Periodicals
Restaurant Brands deal for Domino's 'likely,' 680 NEWS Toronto reporter says »

Richard Southern of 680…

DPZ

Domino's Pizza

$223.26

1.77 (0.80%)

QSR

Restaurant Brands

$59.54

0.31 (0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 07

    Mar

  • 30

    May

ROKU

Roku

$51.18

3.05 (6.34%)

14:49
02/21/18
02/21
14:49
02/21/18
14:49
Options
Roku Inc (Class A Stock) options imply 26.4% move in share price post-earnings, below median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 26

    Feb

  • 21

    Mar

CGG

CGG SA

$3.97

-0.24 (-5.70%)

14:45
02/21/18
02/21
14:45
02/21/18
14:45
Hot Stocks
Breaking Hot Stocks news story on CGG SA 

CGG SA trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JPM

JPMorgan

$117.30

2.59 (2.26%)

14:45
02/21/18
02/21
14:45
02/21/18
14:45
Recommendations
JPMorgan analyst commentary  »

JPMorgan price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 25

    Feb

  • 27

    Feb

  • 07

    Mar

  • 13

    Mar

  • 13

    Apr

  • 30

    May

  • 14

    Jul

  • 12

    Oct

NGVT

Ingevity

$77.41

5.14 (7.11%)

14:42
02/21/18
02/21
14:42
02/21/18
14:42
Hot Stocks
Ingevity sees $1.5B in revenue, adjusted EBITDA $500M in 2022 »

Comments are from the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.